4 ‐n‐butylresorcinol enhances proteolytic degradation of tyrosinase in B16F10 melanoma cells

Conclusion4‐n‐butylresorcinol inhibits melanogenesis by enhancing proteolytic degradation of tyrosinase as well as competitive binding to tyrosinase. These findings will help to develop new, effective, and safe chemicals for the treatment of hyperpigmentation disorders.This article is protected by copyright. All rights reserved.
Source: International Journal of Cosmetic Science - Category: Dermatology Authors: Tags: Original Article Source Type: research